ID CAC1D_RAT Reviewed; 2203 AA. AC P27732; O09022; O09023; O09024; Q01542; Q62691; Q62815; Q63491; Q63492; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1999, sequence version 2. DT 24-JAN-2024, entry version 178. DE RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1D; DE AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 2; DE AltName: Full=Rat brain class D; DE Short=RBD; DE AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.3; GN Name=Cacna1d; Synonyms=Cach3, Cacn4, Cacnl1a2, Cchl1a2; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Insulinoma; RX PubMed=7760845; DOI=10.1210/mend.9.1.7760845; RA Ihara Y., Yamada Y., Fujii Y., Gonoi T., Yano H., Yasuda K., Inagaki N., RA Seino Y., Seino S.; RT "Molecular diversity and functional characterization of voltage-dependent RT calcium channels (CACN4) expressed in pancreatic beta-cells."; RL Mol. Endocrinol. 9:121-130(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 6; 7; 8 AND 13). RC TISSUE=Brain; RX PubMed=1648940; DOI=10.1016/0896-6273(91)90072-8; RA Hui A., Ellinor P.T., Krizanova O., Wang J.-J., Diebold R.J., Schwartz A.; RT "Molecular cloning of multiple subtypes of a novel rat brain isoform of the RT alpha-1 subunit of the voltage-dependent calcium channel."; RL Neuron 7:35-44(1991). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-125. RX PubMed=7553731; DOI=10.1007/bf02089942; RA Kamp T.J., Mitas M., Fields K.L., Asoh S., Chin H., Marban E., RA Nirenberg M.; RT "Transcriptional regulation of the neuronal L-type calcium channel alpha 1D RT subunit gene."; RL Cell. Mol. Neurobiol. 15:307-326(1995). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1100-1410 (ISOFORMS 4 AND 11). RC TISSUE=Kidney; RX PubMed=1279681; DOI=10.1073/pnas.89.21.10494; RA Yu A.S.L., Hebert S.C., Brenner B.M., Lytton J.; RT "Molecular characterization and nephron distribution of a family of RT transcripts encoding the pore-forming subunit of Ca2+ channels in the RT kidney."; RL Proc. Natl. Acad. Sci. U.S.A. 89:10494-10498(1992). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1218-1498 (ISOFORM 12). RC TISSUE=Osteosarcoma; RX PubMed=7479909; DOI=10.1073/pnas.92.24.10914; RA Barry E.L.R., Gesek F.A., Froehner S.C., Friedman P.A.; RT "Multiple calcium channel transcripts in rat osteosarcoma cells: selective RT activation of alpha 1D isoform by parathyroid hormone."; RL Proc. Natl. Acad. Sci. U.S.A. 92:10914-10918(1995). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1200-1493 (ISOFORMS 3; 4; 5; 9 AND 10). RC TISSUE=Hepatoma; RX PubMed=9232351; DOI=10.1016/s0143-4160(97)90088-9; RA Brereton H.M., Harland M.L., Froscio M., Petronijevic T., Barritt G.J.; RT "Novel variants of voltage-operated calcium channel alpha-1 subunit RT transcripts in a rat liver-derived cell line: deletion in the IVS4 voltage RT sensing region."; RL Cell Calcium 22:39-52(1997). RN [7] RP NUCLEOTIDE SEQUENCE OF 1307-1479 (ISOFORM 3). RX PubMed=1692134; DOI=10.1073/pnas.87.9.3391; RA Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., Davidson N.; RT "Rat brain expresses a heterogeneous family of calcium channels."; RL Proc. Natl. Acad. Sci. U.S.A. 87:3391-3395(1990). RN [8] RP FUNCTION, MUTAGENESIS OF 1656-ILE-GLN-1657, INTERACTION WITH CABP1 AND RP CABP4, AND TISSUE SPECIFICITY. RX PubMed=17050707; DOI=10.1523/jneurosci.3236-06.2006; RA Yang P.S., Alseikhan B.A., Hiel H., Grant L., Mori M.X., Yang W., RA Fuchs P.A., Yue D.T.; RT "Switching of Ca2+-dependent inactivation of Ca(v)1.3 channels by calcium RT binding proteins of auditory hair cells."; RL J. Neurosci. 26:10677-10689(2006). CC -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry CC of calcium ions into excitable cells and are also involved in a variety CC of calcium-dependent processes, including muscle contraction, hormone CC or neurotransmitter release, gene expression, cell motility, cell CC division and cell death. The isoform alpha-1D gives rise to L-type CC calcium currents. Long-lasting (L-type) calcium channels belong to the CC 'high-voltage activated' (HVA) group. They are blocked by CC dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines. CC {ECO:0000269|PubMed:17050707}. CC -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit complexes, CC consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 CC ratio. The channel activity is directed by the pore-forming and CC voltage-sensitive alpha-1 subunit. In many cases, this subunit is CC sufficient to generate voltage-sensitive calcium channel activity. The CC auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge CC regulate the channel activity. Interacts with CABP1 and CABP4, CC resulting in a near elimination of calcium-dependent inactivation of CC the channel. Interacts with RIMBP2 (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC P27732; O88871: Gabbr2; NbExp=6; IntAct=EBI-8072674, EBI-7090239; CC P27732; Q9QX74-7: Shank2; NbExp=2; IntAct=EBI-8072674, EBI-20939146; CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=13; CC Comment=The region sequenced in isoforms ROB3 and RKC5 is identical CC to CACN4.; CC Name=1; Synonyms=CACN4A; CC IsoId=P27732-1; Sequence=Displayed; CC Name=2; Synonyms=CACN4B; CC IsoId=P27732-2; Sequence=VSP_000923, VSP_000924; CC Name=3; Synonyms=CACH3A, RB48, RBD-55; CC IsoId=P27732-3; Sequence=VSP_000921; CC Name=4; Synonyms=Delta-IV-S3, RKC6; CC IsoId=P27732-4; Sequence=VSP_000919; CC Name=5; Synonyms=Delta-IV-S4; CC IsoId=P27732-5; Sequence=VSP_000922; CC Name=6; Synonyms=RB9; CC IsoId=P27732-6; Sequence=VSP_000920, VSP_000921; CC Name=7; Synonyms=RB11; CC IsoId=P27732-7; Sequence=VSP_000917; CC Name=8; Synonyms=RB34; CC IsoId=P27732-8; Sequence=VSP_000916; CC Name=9; Synonyms=RH1; CC IsoId=P27732-9; Sequence=VSP_000918; CC Name=10; Synonyms=RH2; CC IsoId=P27732-10; Sequence=VSP_000919, VSP_000922; CC Name=11; Synonyms=RKC5; CC IsoId=P27732-13; Sequence=Not described; CC Name=12; Synonyms=ROB3; CC IsoId=P27732-14; Sequence=Not described; CC Name=13; Synonyms=Truncated; CC IsoId=P27732-12; Sequence=VSP_000925, VSP_000926; CC -!- TISSUE SPECIFICITY: Expressed in brain, pancreatic islets and B- CC lymphocytes. {ECO:0000269|PubMed:17050707}. CC -!- DOMAIN: Each of the four internal repeats contains five hydrophobic CC transmembrane segments (S1, S2, S3, S5, S6) and one positively charged CC transmembrane segment (S4). S4 segments probably represent the voltage- CC sensor and are characterized by a series of positively charged amino CC acids at every third position. CC -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit CC (TC 1.A.1.11) family. CACNA1D subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D38101; BAA07282.1; -; mRNA. DR EMBL; D38102; BAA07283.1; -; mRNA. DR EMBL; M57682; AAA42015.1; -; mRNA. DR EMBL; U14005; AAB60515.1; -; Genomic_DNA. DR EMBL; M99221; AAA40895.1; -; mRNA. DR EMBL; U31772; AAA89156.1; -; mRNA. DR EMBL; U49126; AAB61634.1; -; mRNA. DR EMBL; U49127; AAB61635.1; -; mRNA. DR EMBL; U49128; AAB61636.1; -; mRNA. DR PIR; JH0422; JH0422. DR PIR; T42742; T42742. DR RefSeq; NP_058994.1; NM_017298.1. DR AlphaFoldDB; P27732; -. DR SMR; P27732; -. DR BioGRID; 248333; 2. DR DIP; DIP-60740N; -. DR IntAct; P27732; 5. DR MINT; P27732; -. DR STRING; 10116.ENSRNOP00000043046; -. DR BindingDB; P27732; -. DR ChEMBL; CHEMBL4132; -. DR DrugCentral; P27732; -. DR GuidetoPHARMACOLOGY; 530; -. DR TCDB; 1.A.1.11.1; the voltage-gated ion channel (vic) superfamily. DR GlyCosmos; P27732; 3 sites, No reported glycans. DR GlyGen; P27732; 3 sites. DR iPTMnet; P27732; -. DR PhosphoSitePlus; P27732; -. DR PaxDb; 10116-ENSRNOP00000051407; -. DR ABCD; P27732; 2 sequenced antibodies. DR AGR; RGD:70973; -. DR RGD; 70973; Cacna1d. DR eggNOG; KOG2301; Eukaryota. DR InParanoid; P27732; -. DR OrthoDB; 1110761at2759; -. DR PhylomeDB; P27732; -. DR Reactome; R-RNO-422356; Regulation of insulin secretion. DR PRO; PR:P27732; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0016324; C:apical plasma membrane; IDA:RGD. DR GO; GO:0009986; C:cell surface; IDA:RGD. DR GO; GO:0098683; C:cochlear hair cell ribbon synapse; ISO:RGD. DR GO; GO:0032590; C:dendrite membrane; IDA:RGD. DR GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISO:RGD. DR GO; GO:0043204; C:perikaryon; IDA:RGD. DR GO; GO:0005886; C:plasma membrane; ISO:RGD. DR GO; GO:0048787; C:presynaptic active zone membrane; ISO:RGD. DR GO; GO:0150001; C:primary dendrite; IDA:RGD. DR GO; GO:0042383; C:sarcolemma; IDA:RGD. DR GO; GO:0005891; C:voltage-gated calcium channel complex; ISO:RGD. DR GO; GO:0030018; C:Z disc; ISO:RGD. DR GO; GO:0051393; F:alpha-actinin binding; ISO:RGD. DR GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL. DR GO; GO:0005262; F:calcium channel activity; ISO:RGD. DR GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:RGD. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0030165; F:PDZ domain binding; IDA:RGD. DR GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL. DR GO; GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; IC:BHF-UCL. DR GO; GO:0099626; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels; ISO:RGD. DR GO; GO:0086059; F:voltage-gated calcium channel activity involved SA node cell action potential; ISO:RGD. DR GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; ISO:RGD. DR GO; GO:0070509; P:calcium ion import; IMP:RGD. DR GO; GO:0098703; P:calcium ion import across plasma membrane; IBA:GO_Central. DR GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD. DR GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL. DR GO; GO:0019722; P:calcium-mediated signaling; IDA:RGD. DR GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISO:RGD. DR GO; GO:1904646; P:cellular response to amyloid-beta; IEP:RGD. DR GO; GO:0051649; P:establishment of localization in cell; ISO:RGD. DR GO; GO:0007507; P:heart development; IEP:RGD. DR GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL. DR GO; GO:0086046; P:membrane depolarization during SA node cell action potential; ISO:RGD. DR GO; GO:0007613; P:memory; IEP:RGD. DR GO; GO:0030001; P:metal ion transport; IMP:RGD. DR GO; GO:0021554; P:optic nerve development; IEP:RGD. DR GO; GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:UniProtKB. DR GO; GO:1904879; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; IMP:RGD. DR GO; GO:0051928; P:positive regulation of calcium ion transport; ISO:RGD. DR GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:RGD. DR GO; GO:1904181; P:positive regulation of membrane depolarization; IDA:RGD. DR GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISO:RGD. DR GO; GO:0051924; P:regulation of calcium ion transport; IDA:BHF-UCL. DR GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD. DR GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISO:RGD. DR GO; GO:0032355; P:response to estradiol; IEP:RGD. DR GO; GO:0007605; P:sensory perception of sound; ISO:RGD. DR Gene3D; 1.10.287.70; -; 4. DR Gene3D; 6.10.250.2180; -; 1. DR Gene3D; 6.10.250.2500; -; 1. DR Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4. DR InterPro; IPR031688; CAC1F_C. DR InterPro; IPR031649; GPHH_dom. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR005452; LVDCC_a1dsu. DR InterPro; IPR014873; VDCC_a1su_IQ. DR InterPro; IPR005446; VDCC_L_a1su. DR InterPro; IPR002077; VDCCAlpha1. DR InterPro; IPR027359; Volt_channel_dom_sf. DR PANTHER; PTHR45628; VOLTAGE-DEPENDENT CALCIUM CHANNEL TYPE A SUBUNIT ALPHA-1; 1. DR PANTHER; PTHR45628:SF11; VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1D; 1. DR Pfam; PF08763; Ca_chan_IQ; 1. DR Pfam; PF16885; CAC1F_C; 2. DR Pfam; PF16905; GPHH; 1. DR Pfam; PF00520; Ion_trans; 4. DR PRINTS; PR00167; CACHANNEL. DR PRINTS; PR01630; LVDCCALPHA1. DR PRINTS; PR01636; LVDCCALPHA1D. DR SMART; SM01062; Ca_chan_IQ; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 4. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Calcium channel; Calcium transport; KW Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane; KW Metal-binding; Phosphoprotein; Reference proteome; Repeat; Transmembrane; KW Transmembrane helix; Transport; Voltage-gated channel. FT CHAIN 1..2203 FT /note="Voltage-dependent L-type calcium channel subunit FT alpha-1D" FT /id="PRO_0000053936" FT TOPO_DOM 1..126 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 127..145 FT /note="Helical; Name=S1 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 146..163 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 164..183 FT /note="Helical; Name=S2 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 184..195 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 196..214 FT /note="Helical; Name=S3 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 215..235 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 236..254 FT /note="Helical; Name=S4 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 255..273 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 274..293 FT /note="Helical; Name=S5 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 294..381 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 382..406 FT /note="Helical; Name=S6 of repeat I" FT /evidence="ECO:0000255" FT TOPO_DOM 407..582 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 583..602 FT /note="Helical; Name=S1 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 603..617 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 618..636 FT /note="Helical; Name=S2 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 637..644 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 645..663 FT /note="Helical; Name=S3 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 664..673 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 674..692 FT /note="Helical; Name=S4 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 693..711 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 712..732 FT /note="Helical; Name=S5 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 733..786 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 787..811 FT /note="Helical; Name=S6 of repeat II" FT /evidence="ECO:0000255" FT TOPO_DOM 812..945 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 946..964 FT /note="Helical; Name=S1 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 965..980 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 981..1000 FT /note="Helical; Name=S2 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 1001..1012 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1013..1031 FT /note="Helical; Name=S3 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 1032..1037 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1038..1057 FT /note="Helical; Name=S4 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 1058..1076 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1077..1096 FT /note="Helical; Name=S5 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 1097..1186 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1187..1207 FT /note="Helical; Name=S6 of repeat III" FT /evidence="ECO:0000255" FT TOPO_DOM 1208..1264 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1265..1283 FT /note="Helical; Name=S1 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1284..1298 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1299..1318 FT /note="Helical; Name=S2 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1319..1325 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1326..1347 FT /note="Helical; Name=S3 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1348..1357 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1358..1377 FT /note="Helical; Name=S4 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1378..1396 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1397..1416 FT /note="Helical; Name=S5 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1417..1483 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1484..1508 FT /note="Helical; Name=S6 of repeat IV" FT /evidence="ECO:0000255" FT TOPO_DOM 1509..2203 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 112..408 FT /note="I" FT REPEAT 528..774 FT /note="II" FT REPEAT 892..1174 FT /note="III" FT REPEAT 1211..1486 FT /note="IV" FT REGION 1..51 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 64..100 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 429..446 FT /note="Binding to the beta subunit" FT /evidence="ECO:0000250" FT REGION 449..480 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 822..909 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1134..1224 FT /note="Dihydropyridine binding" FT /evidence="ECO:0000250" FT REGION 1464..1530 FT /note="Dihydropyridine binding" FT /evidence="ECO:0000250" FT REGION 1476..1519 FT /note="Phenylalkylamine binding" FT /evidence="ECO:0000250" FT REGION 1734..1766 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1795..1816 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1920..1963 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2176..2195 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 35..51 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 462..480 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 822..847 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 848..862 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 863..881 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 882..897 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1736..1755 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1795..1809 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1921..1950 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 364 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P07293" FT BINDING 764 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P07293" FT BINDING 1160 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P07293" FT CARBOHYD 155 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 225 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 329 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 481..492 FT /note="Missing (in isoform 8)" FT /evidence="ECO:0000303|PubMed:1648940" FT /id="VSP_000916" FT VAR_SEQ 493..512 FT /note="Missing (in isoform 7)" FT /evidence="ECO:0000303|PubMed:1648940" FT /id="VSP_000917" FT VAR_SEQ 1322..1392 FT /note="Missing (in isoform 9)" FT /evidence="ECO:0000303|PubMed:9232351" FT /id="VSP_000918" FT VAR_SEQ 1322..1349 FT /note="Missing (in isoform 4 and isoform 10)" FT /evidence="ECO:0000303|PubMed:1279681, FT ECO:0000303|PubMed:9232351" FT /id="VSP_000919" FT VAR_SEQ 1322..1348 FT /note="GYFSDAWNTFDSLIVIGSIIDVALSEA -> HYFTDAWNTFDALIVVGSVVD FT IAITEVN (in isoform 6)" FT /evidence="ECO:0000303|PubMed:1648940" FT /id="VSP_000920" FT VAR_SEQ 1349 FT /note="D -> DPSDSENIPLPTATPG (in isoform 6 and isoform 3)" FT /evidence="ECO:0000303|PubMed:1648940, FT ECO:0000303|PubMed:9232351" FT /id="VSP_000921" FT VAR_SEQ 1354..1368 FT /note="Missing (in isoform 10 and isoform 5)" FT /evidence="ECO:0000303|PubMed:9232351" FT /id="VSP_000922" FT VAR_SEQ 1642..1668 FT /note="DDEVTVGKFYATFLIQDYFRKFKKRKE -> GNSRSGKSKAWWGNTLRRTPR FT SPYRRD (in isoform 2)" FT /evidence="ECO:0000303|PubMed:7760845" FT /id="VSP_000923" FT VAR_SEQ 1669..2203 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:7760845" FT /id="VSP_000924" FT VAR_SEQ 1686..1691 FT /note="AGLRTL -> MLERML (in isoform 13)" FT /evidence="ECO:0000303|PubMed:1648940" FT /id="VSP_000925" FT VAR_SEQ 1692..2203 FT /note="Missing (in isoform 13)" FT /evidence="ECO:0000303|PubMed:1648940" FT /id="VSP_000926" FT MUTAGEN 1656..1657 FT /note="IQ->AA: Loss of calcium-dependent inactivation FT related to the C-terminal lobe of calmodulin." FT /evidence="ECO:0000269|PubMed:17050707" FT CONFLICT 124 FT /note="D -> N (in Ref. 2; AAA42015)" FT /evidence="ECO:0000305" FT CONFLICT 183 FT /note="S -> Y (in Ref. 2; AAA42015)" FT /evidence="ECO:0000305" FT CONFLICT 192 FT /note="S -> Y (in Ref. 2; AAA42015)" FT /evidence="ECO:0000305" FT CONFLICT 513 FT /note="G -> C (in Ref. 2)" FT /evidence="ECO:0000305" FT CONFLICT 522..560 FT /note="Missing (in Ref. 2)" FT /evidence="ECO:0000305" FT CONFLICT 1452 FT /note="W -> R (in Ref. 5; AAA89156)" FT /evidence="ECO:0000305" SQ SEQUENCE 2203 AA; 250136 MW; 8E746A8D988050C6 CRC64; MMMMMMMKKM QHQRQQQEDH ANEANYARGT RLPISGEGPT SQPNSSKQTV LSWQAAIDAA RQAKAAQTMS TSAPPPVGSL SQRKRQQYAK SKKQGNSSNS RPARALFCLS LNNPIRRACI SIVDWKPFDI FILLAIFANC VALAIYIPFP EDDSNSTNHN LEKVEYAFLI IFTVETFLKI IASGLLLHPN ASVRNGWNLL DFVIVIVGLF SVILEQLTKE TEGGNHSSGK SGGFDVKALR AFRVLRPLRL VSGVPSLQVV LNSIIKAMVP LLHIALLVLF VIIIYAIIGL ELFIGKMHKT CFFADSDIVA EEDPAPCAFS GNGRQCAANG TECRSGWVGP NGGITNFDNF AFAMLTVFQC ITMEGWTDVL YWVNDAIGWE WPWVYFVSLI ILGSFFVLNL VLGVLSGEFS KEREKAKARG DFQKLREKQQ LEEDLKGYLD WITQAEDIDP ENEEEGGEEG KRNTSMPTSE TESVNTENVS GEGETQGCCG SLWCWWKRRG AAKTGPSGCR RWGQAISKSK LRSHGAREAL CVCRCSLESL VKLWTSRFSA HLQAAYVRPY SRRWRRWNRF NRRRCRAAVK SVTFYWLVIV LVFLNTLTIS SEHYNQPDWL TQIQDIANKV LLALFTCEML VKMYSLGLQA YFVSLFNRFD CFVVCGGITE TILVELELMS PLGVSVFRCV RLLRIFKVTR HWTSLSNLVA SLLNSMKSIA SLLLLLFLFI IIFSLLGMQL FGGKFNFDET QTKRSTFDNF PQALLTVFQI LTGEDWNAVM YDGIMAYGGP SSSGMIVCIY FIILFICGNY ILLKLFLAIA VDNLADAESL NTAQKEEAEE KERKKIARKE SLENKKNNKP EVNQIANSDN KVTIDDYQEE AEDKDPYPPC DVPVGEEEEE EEEDEPEVPA GPRPRRISEL NMKEKIAPIP EGSAFFILSK TNPIRVGCHK LINHHIFTNL ILVFIMLSSA ALAAEDPIRS HSFRNTILGY FDYAFTAIFT VEILLKMTTF GAFLHKGAFC RNYFNLLDML VVGVSLVSFG IQSSAISVVK ILRVLRVLRP LRAINRAKGL KHVVQCVFVA IRTIGNIMIV TTLLQFMFAC IGVQLFKGKF YRCTDEAKSN PEECRGLFIL YKDGDVDSPV VRERIWQNSD FNFDNVLSAM MALFTVSTFE GWPALLYKAI DSNGENVGPV YNYRVEISIF FIIYIIIVAF FMMNIFVGFV IVTFQEQGEK EYKNCELDKN QRQCVEYALK ARPLRRYIPK NPYQYKFWYV VNSSPFEYMM FVLIMLNTLC LAMQHYEQSK MFNDAMDILN MVFTGVFTVE MVLKVIAFKP KGYFSDAWNT FDSLIVIGSI IDVALSEADN SEESNRISIT FFRLFRVMRL VKLLSRGEGI RTLLWTFIKS FQALPYVALL IAMLFFIYAV IGMQMFGKVA MRDNNQINRN NNFQTFPQAV LLLFRCATGE AWQEIMLACL PGKLCDPDSD YNPGEEYTCG SNFAIVYFIS FYMLCAFLII NLFVAVIMDN FDYLTRDWSI LGPHHLDEFK RIWSEYDPEA KGRIKHLDVV TLLRRIQPPL GFGKLCPHRV ACKRLVAMNM PLNSDGTVMF NATLFALVRT ALKIKTEGNL EQANEELRAV IKKIWKKTSM KLLDQVVPPA GDDEVTVGKF YATFLIQDYF RKFKKRKEQG LVGKYPAKNT TIALQAGLRT LHDIGPEIRR AISCDLQDDE PEDSKPEEED VFKRNGALLG NYVNHVNSDR RESLQQTNTT HRPLHVQRPS IPPASDTEKP LFPPAGNSVC HNHHNHNSIG KQVPTSTNAN LNNANMSKAA HGKRPSIGDL EHVSENGHYS YKHDRELQRR SSIKRTRYYE TYIRSESGDE QLPTIFREDP EIHGYFRDPR CFGEQEYFSS EECCEDDSSP TWSRQNYSYY NRYPGSSMDF ERPRGYHHPQ GFLEDDDSPI GYDSRRSPRR RLLPPTPPSH RRSSFNFECL RRQNSQDDVL PSPALPHRAA LPLHLMQQQI MAVAGLDSSK AQKYSPSHST RSWATPPATP PYRDWTPCYT PLIQVDRSES MDQVNGSLPS LHRSSWYTDE PDISYRTFTP ASLTVPSSFR NKNSDKQRSA DSLVEAVLIS EGLGRYARDP KFVSATKHEI ADACDLTIDE MESAASTLLN GSVCPRANGD MGPISHRQDY ELQDFGPGYS DEEPDPGREE EDLADEMICI TTL //